MOLECULAR DOCKING AND ADMET STUDIES OF ETHANONE, 1-(2-HYDROXY-5-METHYL PHENYL) FOR ANTI-MICROBIAL PROPERTIES

Authors

  • MEDICHARLA SRI SATYA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bangalore, India https://orcid.org/0000-0003-3666-7731
  • SUMA B. V. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bangalore, India
  • AISWARIYA Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bangalore, India

DOI:

https://doi.org/10.22159/ijpps.2022v14i6.44548

Keywords:

Ethanone 1-(2-hydroxy-5-methyl phenyl), SWISS ADME, PyRx, Discovery studios 2021, Swiss-Pdb viewer

Abstract

Objective: Ethanone 1-(2-hydroxy-5-methyl phenyl) found in the aerial parts of Rhizophora mucronate, Epiphyllum oxypetalum haw and dried ripened seed extracts of coffee. It has reported anti-microbial properties based on the literature. The objective of the present study is to find the binding efficacy of the compound with proteins in staphylococcus aureus and to report the ADMET properties of the compound.

Methods: Rigid docking technique was used for finding the affinities.3D structures of the six proteins of staphylococcus aureus are selected from the protein database. Molecule Ethanone 1-(2-hydroxy-5-methyl phenyl) is obtained from PubChem. ADMET studies of the compound are assessed by SWISS-ADME. Molecular docking studies are carried out by using PyRx software.

Results: Ethanone 1-(2-hydroxy-5-methyl phenyl) on molecular docking with Staphylococcus aureus sortase-A (PDB ID: 1T2P), Clumping factor A (ClfA) (PDB ID: 1N67), DNA gyrase (PDB ID: 3U2D), Dihydrofolate reductase (DHFR) (PDB ID: 2W9S), Undecaprenyl diphosphate synthase (UPPS) (PDB ID: 4H8E), Dehydrosqualene synthase (CrtM) (PDB ID: 2ZCO), their binding affinities were found to be-6.2,-6.3,-5.9,-6.4,-5.3,-6.8 respectively. Out of six proteins, Dehydrosqualene synthase (CrtM) (PDB ID: 2ZCO) and Dihydrofolate reductase (DHFR) (PDB ID: 2W9S) has shown better binding affinities.

Conclusion: ADMET studies show that Ethanone 1-(2-hydroxy-5-methyl phenyl) has zero violation to Lipinski’s rule and molecular docking with two proteins has shown good binding efficacy with Ethanone 1-(2-hydroxy-5-methylphenyl).

Downloads

Download data is not yet available.

References

Kumar M, Nehra K, Duhan JS. Phytochemical analysis and antimicrobial efficacy of leaf extracts of pithecellobium dulce. Asian J Pharm Clin Res. 2013;6(1):70-6.

Subramanian N, Jothimanivannan C, Moorthy K. Antimicrobial activity and preliminary phytochemical screening of Justicia Gendarussa (Burm. f.) against human pathogens. Asian J Pharm Clin Res. 2012;5(3):229-33.

Mahmad A, Shaharun M, Saad B, Dash KG. Epiphyllum oxypetalum haw: A lesser-known medicinal plant. Indo American Journal of Pharmaceutical Sciences. 2017;2349-7750:3671.

Kakkassery J, Raphael V, Johnson RKV. In vitro antibacterial and in silico docking studies of two schiff bases on staphylococcus aureus and its target proteins. K, R. Future J Pharm Sci. 2021;7(1):1-8.

Biovia DS. [Discovery Studio. San Diego: Dassault Systemes: 2021.

Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243-50. doi: 10.1007/978-1-4939-2269-7_19, PMID 25618350.

Schrodinger L, DeLano W. PyMOL. Available from: http://www.pymol.org/pymol. [Last accessed on 15 Oct 2020]

Ferreira LLG, Andricopulo AD. ADMET modeling approaches in drug discovery. Drug Discov Today. 2019;24(5):1157-65. doi: 10.1016/j.drudis.2019.03.015, PMID 30890362.

Dorcheh FA, Balmeh N, Sanjari S. In silico investigation of antibacterial herbal compounds in order to find new antibiotic against Staphylococcus aureus and its resistant subtypes. Inform Med Unlocked. 2022;28:100843. doi: 10.1016/j.imu.2021.100843.

Published

01-06-2022

How to Cite

SRI SATYA, M., S. B. V., and AISWARIYA. “MOLECULAR DOCKING AND ADMET STUDIES OF ETHANONE, 1-(2-HYDROXY-5-METHYL PHENYL) FOR ANTI-MICROBIAL PROPERTIES”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 6, June 2022, pp. 24-27, doi:10.22159/ijpps.2022v14i6.44548.

Issue

Section

Short Communication(s)